Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Somatostatin antagonist induces catalepsy in the aged rat.

Ionov ID, Pushinskaya II.

Psychopharmacology (Berl). 2013 May;227(2):273-6. doi: 10.1007/s00213-012-2961-0. Epub 2012 Dec 29.

PMID:
23274508
2.

Somatostatin antagonist potentiates haloperidol-induced catalepsy in the aged rat.

Ionov ID, Severtsev NN.

Pharmacol Biochem Behav. 2012 Dec;103(2):295-8. doi: 10.1016/j.pbb.2012.08.006. Epub 2012 Aug 20.

PMID:
23036801
3.

Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L-DOPA.

Ionov ID, Severtsev NN.

Psychopharmacology (Berl). 2012 Sep;223(2):191-7. doi: 10.1007/s00213-012-2706-0. Epub 2012 Apr 13.

PMID:
22526536
4.

Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice.

Echeverry MB, Salgado ML, Ferreira FR, da-Silva CA, Del Bel EA.

Psychopharmacology (Berl). 2007 Oct;194(2):271-8. Epub 2007 Jun 26.

PMID:
17593355
5.

Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.

Banasikowski TJ, Beninger RJ.

Int J Neuropsychopharmacol. 2012 Nov;15(10):1525-34. doi: 10.1017/S1461145711001696. Epub 2011 Nov 18.

PMID:
22093169
6.

Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy.

Moo-Puc RE, Góngora-Alfaro JL, Alvarez-Cervera FJ, Pineda JC, Arankowsky-Sandoval G, Heredia-López F.

Neuropharmacology. 2003 Sep;45(4):493-503.

PMID:
12907310
7.

Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy.

Johnson SK, Fisher H, Wagner GC.

Neuropharmacology. 1993 Mar;32(3):273-8.

PMID:
8474623
8.

[Effect of intracerebral administration of somatostatin and neurotensin on posture and movement disorders].

Shandra OA, Hodlevskyĭ LS, Panenko AV, Vastíanov RS, Oliĭnyk AA.

Fiziol Zh. 1994 Jan-Feb;40(1):71-7. Ukrainian.

PMID:
7713229
9.

Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.

Banasikowski TJ, Beninger RJ.

Eur Neuropsychopharmacol. 2012 Oct;22(10):761-8. doi: 10.1016/j.euroneuro.2012.02.004. Epub 2012 Mar 10.

PMID:
22410316
10.

Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.

Ninan I, Kulkarni SK.

Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):603-8.

PMID:
10669905
11.

Effects of age and isolation on the evolution of catalepsy during chronic haloperidol treatment.

Frussa-Filho R, Otoboni JR, Uema FT, Palermo-Neto J.

Braz J Med Biol Res. 1992;25(9):925-8.

PMID:
1342840
12.

Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.

Jelovac N, Sikiric P, Rucman R, Petek M, Marovic A, Perovic D, Seiwerth S, Mise S, Turkovic B, Dodig G, Miklic P, Buljat G, Prkacin I.

Eur J Pharmacol. 1999 Aug 20;379(1):19-31.

PMID:
10499368
13.

Central activity of 2-amino-3-phosphonopropionic acid (AP3) and its N-methyl analog.

Winnicka MM, Wiśniewski K, Kupczyk-Subotkowska L, Subotkowski W, Mastalerz P.

Pol J Pharmacol. 1994 Sep-Oct;46(5):395-401.

PMID:
7894525
14.
15.

Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.

Góngora-Alfaro JL, Moo-Puc RE, Villanueva-Toledo JR, Alvarez-Cervera FJ, Bata-García JL, Heredia-López FJ, Pineda JC.

Neurosci Lett. 2009 Oct 9;463(3):210-4. doi: 10.1016/j.neulet.2009.07.084. Epub 2009 Aug 3.

PMID:
19654037
16.
17.

Differential effects of morphinan drugs on haloperidol-induced catalepsy in rats: a comparative study with an N-methyl-D-aspartate antagonist.

Scotti de Carolis A, Popoli P, Pezzola A, Sagratella S.

Arch Int Pharmacodyn Ther. 1991 Mar-Apr;310:132-41.

PMID:
1685312
18.

[Minute rhythms of haloperidol catalepsy in rats].

Arushanian EB, Popova AP.

Biull Eksp Biol Med. 1986 Jan;101(1):89-91. Russian.

PMID:
3942822
19.

Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy.

Naidu PS, Kulkarni SK.

Methods Find Exp Clin Pharmacol. 2004 Jun;26(5):323-6.

PMID:
15319809
20.

Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.

Mahmoudi J, Nayebi AM, Samini M, Reyhani-Rad S, Babapour V.

Pharmacol Rep. 2011;63(4):908-14.

Items per page

Supplemental Content

Write to the Help Desk